Cellebrite DI (CLBT) News Today $19.00 +0.24 (+1.28%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Empowered Funds LLC Takes $2 Million Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Empowered Funds LLC bought a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 118,890 shares of the company's stock, vNovember 21 at 3:50 AM | marketbeat.comCellebrite DI Ltd. (CLBT) Partners with Relativity to Streamline Mobile Data Collection for Legal Processes, Reducing Time from Days to HoursNovember 21 at 1:06 AM | insidermonkey.comCellebrite, Relativity deliver solutions to transform mobile data collectionNovember 20 at 8:40 PM | markets.businessinsider.comCellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection LandscapeNovember 20 at 8:30 AM | globenewswire.comCellebrite DI Ltd. (NASDAQ:CLBT) Given Consensus Rating of "Buy" by AnalystsCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has been given a consensus rating of "Buy" by the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating. The average 1-year target price among brNovember 18 at 1:09 AM | marketbeat.comIs Cellebrite (CLBT) Poised to Develop And Sell The Next Generation Of AI Analytics Tools?November 16, 2024 | msn.comPrincipal Financial Group Inc. Acquires Shares of 1,389,654 Cellebrite DI Ltd. (NASDAQ:CLBT)Principal Financial Group Inc. bought a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 1,389,654 shares of the company's stock,November 14, 2024 | marketbeat.comCellebrite: A Reasonable Valuation Given The Huge Cross-Sell RunwayNovember 13, 2024 | seekingalpha.comCellebrite: Positioned To Develop And Sell Next-Generation AI Analytics ToolsNovember 12, 2024 | seekingalpha.comGSA Capital Partners LLP Has $2.58 Million Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT)GSA Capital Partners LLP lowered its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 33.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 153,239 shares of the company's stock after sellNovember 12, 2024 | marketbeat.comCellebrite DI: Long-Term Growth Looks Positive, But Valuation IncreasedNovember 11, 2024 | seekingalpha.comCellebrite DI (NASDAQ:CLBT) Issues Earnings ResultsCellebrite DI (NASDAQ:CLBT - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.05. Cellebrite DI had a negative net margin of 82.28% and a negative return on equity of 748.06%. The company had revenue of $106.90 million for the quarter, compared to analysts' expectations of $102.06 million. During the same quarter in the previous year, the company earned $0.09 earnings per share. Cellebrite DI's quarterly revenue was up 27.0% on a year-over-year basis.November 9, 2024 | marketbeat.comARK Investment Management LLC Sells 47,898 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)ARK Investment Management LLC trimmed its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 23.0% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 160,625 shares of the company's stock after selling 47,898 shares during the quarter.November 9, 2024 | marketbeat.comCellebrite: There Are Potential Risks That Could Damper GrowthNovember 8, 2024 | seekingalpha.comCellebrite price target raised to $21 from $17 at Lake StreetNovember 7, 2024 | markets.businessinsider.comCellebrite DI (NASDAQ:CLBT) Price Target Raised to $24.00Craig Hallum increased their price objective on shares of Cellebrite DI from $23.00 to $24.00 and gave the company a "buy" rating in a report on Thursday.November 7, 2024 | marketbeat.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for Cellebrite DI (NASDAQ:CLBT) StockJPMorgan Chase & Co. lifted their price target on Cellebrite DI from $21.00 to $22.00 and gave the stock an "overweight" rating in a research note on Thursday.November 7, 2024 | marketbeat.comNeedham & Company LLC Forecasts Strong Price Appreciation for Cellebrite DI (NASDAQ:CLBT) StockNeedham & Company LLC raised their price objective on Cellebrite DI from $17.00 to $21.00 and gave the company a "buy" rating in a research report on Thursday.November 7, 2024 | marketbeat.comCellebrite DI Ltd (CLBT) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ...November 7, 2024 | finance.yahoo.comCellebrite Reports Record Revenue and Raises 2024 OutlookNovember 7, 2024 | markets.businessinsider.comCellebrite DI: Strong Financial Performance and Growth Potential Justify Buy Rating Despite CEO DepartureNovember 7, 2024 | markets.businessinsider.comCellebrite DI: Strong Performance and Promising Outlook Justify Buy Rating Despite Leadership Transition ConcernsNovember 6, 2024 | markets.businessinsider.comCellebrite DI Ltd. (CLBT) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comCellebrite Announces Third-Quarter 2024 ResultsNovember 6, 2024 | markets.businessinsider.comCellebrite DI Chief Executive Yossi Carmil Stepping DownNovember 6, 2024 | marketwatch.comCORRECTION: Cellebrite Announces Third-Quarter 2024 ResultsNovember 6, 2024 | globenewswire.comYossi Carmil to Step Down as CEO After Nearly 20 YearsNovember 6, 2024 | globenewswire.comHarbor Capital Advisors Inc. Boosts Stock Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)Harbor Capital Advisors Inc. increased its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 96.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 95,351 shares of the company's stock after buying an additiNovember 6, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Sets New 52-Week High - Time to Buy?Cellebrite DI (NASDAQ:CLBT) Reaches New 12-Month High - Here's What HappenedNovember 5, 2024 | marketbeat.comCellebrite DI Ltd (CLBT) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 5, 2024 | finance.yahoo.comAt US$18.53, Is It Time To Put Cellebrite DI Ltd. (NASDAQ:CLBT) On Your Watch List?November 5, 2024 | finance.yahoo.comCellebrite DI Reaches Key Stock MilestoneNovember 5, 2024 | markets.businessinsider.comCraig-Hallum Sticks to Their Buy Rating for Cellebrite DI (CLBT)November 5, 2024 | markets.businessinsider.comCellebrite DI Ltd. (NASDAQ:CLBT) is Pembroke Management LTD's 4th Largest PositionPembroke Management LTD grew its stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 24.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,908,345 shares of the company's stock after acquiring an additional 372,619November 3, 2024 | marketbeat.comLake Street Sticks to Its Buy Rating for Cellebrite DI (CLBT)November 2, 2024 | markets.businessinsider.comMeitav Investment House Ltd. Increases Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Meitav Investment House Ltd. boosted its stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 29.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,066,322 shares of the company's stock after acquOctober 31, 2024 | marketbeat.comCellebrite DI (CLBT) Set to Announce Quarterly Earnings on WednesdayCellebrite DI (NASDAQ:CLBT) will be releasing earnings before the market opens on Wednesday, November 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634608)October 30, 2024 | marketbeat.comCellebrite announces Tim Tebow as keynote for C2C User Summit 2025October 29, 2024 | markets.businessinsider.comCellebrite Announces Tim Tebow as Keynote Speaker for Inaugural Case-to-Closure (C2C) User Summit 2025October 29, 2024 | markets.businessinsider.comCellebrite price target raised to $20 from $17 at BofAOctober 25, 2024 | markets.businessinsider.comSG Americas Securities LLC Reduces Position in Cellebrite DI Ltd. (NASDAQ:CLBT)SG Americas Securities LLC trimmed its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 82.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8,938 shares of the company's stock after selling 42,562 shares durOctober 25, 2024 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for Cellebrite DI (CLBT)October 24, 2024 | markets.businessinsider.comCellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of "Buy" from BrokeragesCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has received an average rating of "Buy" from the eight research firms that are currently covering the stock, Marketbeat.com reports. Eight analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages thOctober 24, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Reaches New 12-Month High - Time to Buy?Cellebrite DI (NASDAQ:CLBT) Reaches New 52-Week High - Should You Buy?October 15, 2024 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Short Interest UpdateCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) was the recipient of a large decline in short interest in September. As of September 30th, there was short interest totalling 1,350,000 shares, a decline of 58.5% from the September 15th total of 3,250,000 shares. Approximately 2.2% of the company's stock are short sold. Based on an average daily trading volume, of 1,370,000 shares, the days-to-cover ratio is currently 1.0 days.October 11, 2024 | marketbeat.comStrategic Advisors LLC Makes New $474,000 Investment in Cellebrite DI Ltd. (NASDAQ:CLBT)Strategic Advisors LLC acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 28,132 shares of the company's stock, valued at approximately $October 10, 2024 | marketbeat.comCellebrite to Report Third-Quarter 2024 Financial Results on November 6, 2024October 10, 2024 | globenewswire.comCellebrite DI Ltd. (NASDAQ:CLBT) Shares Sold by Squarepoint Ops LLCSquarepoint Ops LLC decreased its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 37.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,689 shares of the company's stock after selling 30,October 9, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Hits New 52-Week High - Still a Buy?Cellebrite DI (NASDAQ:CLBT) Sets New 52-Week High - Here's What HappenedOctober 7, 2024 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Shares Sold by Point72 Asset Management L.P.Point72 Asset Management L.P. cut its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 34.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,300 shares of theOctober 5, 2024 | marketbeat.com Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW CLBT Media Mentions By Week CLBT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLBT News Sentiment▼0.670.54▲Average Business Services News Sentiment CLBT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLBT Articles This Week▼64▲CLBT Articles Average Week Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Dynatrace News Twilio News Duolingo News CyberArk Software News Mobileye Global News Bentley Systems News Okta News monday.com News Paycom Software News Dayforce News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLBT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellebrite DI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellebrite DI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
